ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 130 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.95 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $120,000 | +700.0% | 82,697 | +678.8% | 0.01% | +400.0% |
Q4 2016 | $15,000 | -59.5% | 10,618 | -50.9% | 0.00% | -66.7% |
Q3 2016 | $37,000 | +12.1% | 21,641 | +11.7% | 0.00% | +50.0% |
Q2 2016 | $33,000 | -5.7% | 19,366 | +8.2% | 0.00% | -33.3% |
Q1 2016 | $35,000 | +34.6% | 17,892 | +28.8% | 0.00% | +50.0% |
Q4 2015 | $26,000 | +1200.0% | 13,892 | +1017.6% | 0.00% | – |
Q3 2015 | $2,000 | – | 1,243 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 7,500,000 | $34,800,000 | 2.37% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,983,710 | $32,404,000 | 1.08% |
DAFNA Capital Management LLC | 189,000 | $877,000 | 0.74% |
Lyons Wealth Management, LLC. | 56,665 | $264,000 | 0.30% |
Telemetry Investments, L.L.C. | 110,000 | $510,000 | 0.23% |
Callan Capital, LLC | 232,000 | $1,076,000 | 0.23% |
OXFORD ASSET MANAGEMENT LLP | 968,446 | $4,494,000 | 0.12% |
FEDERATED HERMES, INC. | 5,641,200 | $26,175,000 | 0.08% |
HRT FINANCIAL LP | 31,973 | $148,000 | 0.07% |
WELLINGTON MANAGEMENT GROUP LLP | 33,885,551 | $157,230,000 | 0.04% |